Search

Author/Creator Close, David

1. A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis. Issue 6 (17th February 2017)

Authors:
Burmester, Gerd R; McInnes, Iain B; Kremer, Joel; Miranda, Pedro; Korkosz, Mariusz; Vencovsky, Jiri; Rubbert-Roth, Andrea; Mysler, Eduardo; Sleeman, Matthew A; Godwood, Alex; Sinibaldi, Dominic; Guo, Xiang; White, Wendy I; Wang, Bing; Wu, Chi-Yuan; Ryan, Patricia C; Close, David; Weinblatt, Micha...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76:Issue 6(2017)
Page Start:
1020
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis. Issue 1 (27th December 2017)

Authors:
Weinblatt, Michael E.; McInnes, Iain B.; Kremer, Joel M.; Miranda, Pedro; Vencovsky, Jiri; Guo, Xiang; White, Wendy I.; Ryan, Patricia C.; Godwood, Alex; Albulescu, Marius; Close, David; Burmester, Gerd R.
Journal:
Arthritis & rheumatology
Issue:
Volume 70:Issue 1(2018)
Page Start:
49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis. (23rd October 2017)

Authors:
Guo, Xiang; Higgs, Brandon W; Bay-Jensen, Anne-Christine; Wu, Yuling; Karsdal, Morten A; Kuziora, Michael; Godwood, Alex; Close, David; Ryan, Patricia C; Roskos, Lorin K; White, Wendy I
Journal:
Rheumatology
Issue:
Volume 57:Number 1(2018)
Page Start:
175
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double‐Blind, Phase III Study. Issue 9 (26th August 2013)

Authors:
Mysler, Eduardo F.; Spindler, Alberto J.; Guzman, Renato; Bijl, Marc; Jayne, David; Furie, Richard A.; Houssiau, Frédéric A.; Drappa, Jorn; Close, David; Maciuca, Romeo; Rao, Kajal; Shahdad, Saba; Brunetta, Paul
Journal:
Arthritis and rheumatism
Issue:
Volume 65:Issue 9(2013:Sep.)
Page Start:
2368
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double‐Blind, Phase III Study1. Issue 9 (26th August 2013)

Authors:
Mysler, Eduardo F.; Spindler, Alberto J.; Guzman, Renato; Bijl, Marc; Jayne, David; Furie, Richard A.; Houssiau, Frédéric A.; Drappa, Jorn; Close, David; Maciuca, Romeo; Rao, Kajal; Shahdad, Saba; Brunetta, Paul
Journal:
Arthritis and rheumatism
Issue:
Volume 65:Issue 9(2013:Sep.)
Page Start:
2368
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Mavrilimumab, a Fully Human Granulocyte–Macrophage Colony‐Stimulating Factor Receptor α Monoclonal Antibody: Long‐Term Safety and Efficacy in Patients With Rheumatoid Arthritis. Issue 5 (31st March 2018)

Authors:
Burmester, Gerd R.; McInnes, Iain B.; Kremer, Joel M.; Miranda, Pedro; Vencovský, Jiří; Godwood, Alex; Albulescu, Marius; Michaels, M. Alex; Guo, Xiang; Close, David; Weinblatt, Michael
Journal:
Arthritis & rheumatology
Issue:
Volume 70:Issue 5(2018)
Page Start:
679
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗